p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of…

Overview of attention for article published in Breast Cancer Research, January 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
Good Attention Score compared to outputs of the same age and source (68th percentile)

So far, Altmetric has seen 9 X posts from 8 X users, with an upper bound of 51,221 followers.

RT @NatRevClinOncol: Does loss of BTG2 expression in p53-deficient tumours contribute to metastatic potential by enhancing tumour growth: h…

RT @NatRevClinOncol: Does loss of BTG2 expression in p53-deficient tumours contribute to metastatic potential by enhancing tumour growth: h…

RT @NatRevClinOncol: Does loss of BTG2 expression in p53-deficient tumours contribute to metastatic potential by enhancing tumour growth: h…

RT @NatRevClinOncol: Does loss of BTG2 expression in p53-deficient tumours contribute to metastatic potential by enhancing tumour growth: h…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.